CCBs | Diuretics | Beta-blockers | ACE inhibitors | Angiotensin II antagonists | CAM remedy | |
---|---|---|---|---|---|---|
Factor | Adjusted OR (95% CI) | |||||
Gender (male) | 1.21 (0.99-1.48) | 1.02 (0.83-1.25) | 1.15 (0.96-1.36) | 1.44 (1.20-1.74)* | 1.62 (1.26-2.09)* | 0.66 (0.54-0.80)* |
Age (60 years or older) | 1.70 (1.34-2.14)* | 1.10 (0.88-1.38) | 0.50 (0.41-0.60)* | 0.87 (0.70-1.06) | 0.75 (0.57-0.98)* | 1.16 (0.95-1.42) |
Comorbidies1 | 0.87 (0.64-1.18) | 1.09 (0.79-1.49) | 0.99 (0.76-1.30) | 1.57 (1.16-2.11)* | 0.46 (0.30-0.69)* | 0.91 (0.69-1.21) |
Diabetes | 1.01 (0.79-1.29) | 0.98 (0.76-1.25) | 1.63 (1.33-2.00)* | 0.85 (0.67-1.07) | 1.92 (1.42-2.60)* | 0.55 (0.42-0.73)* |
Renal insufficiency | 1.49 (1.09-2.05)* | 1.33 (0.96-1.83) | 0.58 (0.41-0.81)* | 1.05 (0.76-1.44) | 0.66 (0.40-1.10) | 0.89 (0.62-1.28) |
Hypercholesterolaemia | 1.09 (0.87-1.37) | 0.70 (0.56-0.88)* | 1.29 (1.06-1.56)* | 0.93 (0.76-1.15) | 1.74 (1.28-2.36)* | 0.59 (0.47-0.75)* |
CHD | 1.00 (0.79-1.26) | 1.32 (1.05-1.66)* | 1.68 (1.04-1.57)* | 1.31 (1.05-1.62)* | 1.12 (0.82-1.53) | 0.82 (0.64-1.05) |
Post myocardial infarction | 1.27 (0.78-2.07) | 1.43 (0.89-2.32) | 1.30 (0.83-2.04) | 1.69 (1.09-2.62)* | 0.94 (0.47-1.89) | 0.37 (0.17-0.81)* |
Heart failure | 0.72 (0.42-1.23) | 0.98 (0.59-1.60) | 0.30 (0.16-0.59)* | 1.03 (0.64-1.64) | 0.93 (0.44-1.97) | 0.84 (0.51-1.38) |
Stroke | 1.22 (0.93-1.50) | 1.18 (0.90-1.56) | 1.02 (0.79-1.31) | 1.22 (0.94-1.58) | 1.29 (0.87-1.89) | 0.54 (0.40-0.74)* |
Obesity | 0.98 (0.76-1.28) | 1.49 (1.16-1.01)* | 0.79 (0.64-0.99)* | 1.11 (0.88-1.40) | 1.07 (0.77-1.48) | 0.74 (0.57-0.97)* |
Asthma/COPD | 1.41 (1.06-1.88)* | 1.69 (1.23-2.23)* | 0.94 (0.71-1.23) | 0.73 (0.54-0.98)* | 1.44 (0.97-2.13) | 0.91 (0.67-1.24) |